The Visionaries Redefining Science, Startups, and the Future of Healthcare
Switzerland has long stood at the epicenter of global life sciences, home to pharmaceutical giants, cutting-edge research institutions, and a thriving biotech startup ecosystem. From innovation hubs in Zurich and Basel to world-renowned research collaborations, the country continues to shape the future of medicine. Yet, beyond the towering legacy of large corporations lies a powerful and rapidly growing force—women biotech founders who are building the next generation of breakthrough companies.
In recent years, a new wave of female entrepreneurs has emerged, combining scientific rigor with bold business vision. These women are not inheriting influence—they are creating it from the ground up, launching startups that tackle some of the world’s most pressing health challenges, from cancer and rare diseases to AI-driven drug discovery and sustainable biotech solutions.
This feature highlights Switzerland’s Top 10 Women Biotech Founders to Watch in 2026—a carefully curated, founder-first list that celebrates innovation, leadership, and impact. These are the women turning laboratories into launchpads and ideas into global biotech ventures.
1. Martine Clozel: Pioneering the Blueprint for Swiss Biotech Entrepreneurship
No conversation about Swiss biotech founders is complete without Martine Clozel. As the co-founder of Actelion—one of Europe’s most successful biotech companies—and later Idorsia, she has set the gold standard for biotech entrepreneurship in Switzerland.
A trained physician and pharmacologist, Clozel has spent decades transforming scientific discoveries into life-saving therapies. With Idorsia, she continues to lead innovation in drug development, focusing on diseases with high unmet medical needs. Her journey is not just one of success, but also one of resilience, reinvention, and a relentless pursuit of scientific excellence.
2. Michal Shoshan: Engineering Precision Therapies for the Next Generation
Dr. Michal Shoshan, Founder and CEO of metaLead Therapeutics AG, represents the new frontier of targeted medicine. Her company focuses on developing advanced therapeutic solutions that aim to improve precision in drug delivery and efficacy.
With a strong academic and research background, Shoshan bridges the gap between deep science and entrepreneurial execution. Her work is particularly significant in an era where biotech is shifting toward highly personalized and mechanism-driven therapies.
3. Sophie Scherrer: Powering Biotech with Data Intelligence
As the founder of Genedata, Sophie Scherrer has been a quiet yet transformative force in Switzerland’s biotech ecosystem. Her company provides advanced software solutions that enable pharmaceutical and biotech firms to accelerate drug discovery through data-driven insights.
In a world where biology meets big data, Scherrer’s vision has become increasingly critical. She stands at the intersection of AI, data science, and biotechnology, enabling faster, smarter, and more efficient research pipelines.
4. Dr. Clecia Bourgoint: Reinventing Drug Discovery Without Animal Testing
Dr. Clecia Bourgoint, co-founder of FluoSphera, is leading a transformative shift toward ethical and human-relevant drug discovery. Her startup recently secured €1.23 million in funding, signaling strong investor confidence in its innovative approach.
FluoSphera’s technology focuses on eliminating animal testing by creating advanced human-based models, aligning science with both efficiency and ethics. Bourgoint’s work reflects a broader movement in biotech toward sustainability and humane innovation.
5. Sarah Holland: Driving Commercial Strategy in Immunotherapy Innovation
As Chief of Business at CDR-Life Inc., Sarah Holland plays a pivotal role in translating cutting-edge science into viable biotech solutions. While not a founder in the traditional sense, her leadership in scaling biotech ventures places her firmly among Switzerland’s most influential biotech builders.
CDR-Life is known for its work in antibody-based therapies, particularly in oncology and neurodegenerative diseases. Holland’s expertise lies in bridging the gap between scientific innovation and market execution, a critical component of biotech success.
6. Kiran Dallenbach: Fueling the Future of Biotech Startups
Kiran Dallenbach, Partner at BiomedVC, is shaping Switzerland’s biotech landscape from the investment side. As an early-stage venture capitalist, she backs high-potential biotech startups, helping founders navigate the complex journey from lab to market.
Her role is crucial in an ecosystem where access to capital can determine the success of groundbreaking innovations. Dallenbach represents a new generation of investors who combine financial acumen with deep scientific understanding.
7. Amanda Gogates: Translating Research into Real-World Impact
Amanda Gogates, Managing Director at Wyss Zurich, is at the forefront of translating academic research into commercial biotech ventures. The institute is known for bridging the gap between university science and industry applications.
Gogates plays a strategic role in fostering innovation, supporting startups, and accelerating technologies that have the potential to transform healthcare. Her work underscores the importance of ecosystem builders in biotech success.
8. Nina Kullmann: Innovating at the Crossroads of Science and Business
Nina Kullmann is an emerging name in Switzerland’s biotech startup scene, known for her work in advancing early-stage biotech ventures. With a background in both science and business, she exemplifies the hybrid leadership required in modern biotech.
Her focus on innovation and scalability positions her as a founder to watch in the coming years, particularly as Switzerland continues to nurture startup-driven growth.
9. Anja Isabella König: Advancing Therapeutics Through Scientific Excellence
Anja König represents the new generation of biotech founders leveraging cutting-edge research to develop next-generation therapies. Her work focuses on translating complex biological insights into practical medical solutions.
She embodies the spirit of Swiss biotech—precision, innovation, and a commitment to improving patient outcomes.
10. Michela Puddu: Pioneering DNA-Based Traceability for a Transparent Future
Michela Puddu is a Swiss-Italian scientist and entrepreneur recognized for pioneering traceability innovations in sustainable supply chains. As the CEO and co-founder of Haelixa, a spin-off from ETH Zurich, she is leveraging cutting-edge biotechnology to bring unprecedented transparency to global industries.
Her company utilizes DNA-based markers to authenticate products and materials throughout their lifecycle, addressing critical challenges in sustainability, ethics, and supply chain integrity. Puddu’s work sits at the intersection of biotech, sustainability, and advanced materials science, positioning her as a forward-thinking founder redefining how biotechnology can extend beyond healthcare into real-world industrial applications.
The Rise of Women Biotech Founders in Switzerland
Switzerland’s biotech ecosystem is evolving rapidly, and women are playing an increasingly central role in this transformation. Unlike traditional industry structures dominated by legacy wealth and large corporations, today’s founders are building companies rooted in innovation, purpose, and global impact.
Several key trends define this shift:
Science-Driven Entrepreneurship: Many of these founders come from deep scientific backgrounds, bringing unmatched expertise to their ventures.
Collaborative Ecosystems: Institutions, venture capital firms, and innovation hubs are working together to support startups.
Ethical and Sustainable Innovation: From reducing animal testing to developing environmentally responsible solutions, ethics are becoming a core focus.
Data and AI Integration: The convergence of biotech with AI and data science is opening new frontiers in drug discovery and personalized medicine.
Outlook: The Future is Founder-Led
The women featured in this list are not just participants in Switzerland’s biotech story—they are writing its next chapter. Through resilience, innovation, and leadership, they are redefining what it means to build a biotech company in the 21st century.
As global demand for advanced healthcare solutions continues to rise, these founders are uniquely positioned to lead the charge. Their work goes beyond business—it has the potential to save lives, reshape industries, and transform the future of medicine.
In 2026 and beyond, all eyes will be on Switzerland—not just for its legacy, but for the women founders driving its next wave of biotech breakthroughs.
Read more latest update on Top List At Spain’s Top 10 Women CEOs Driving Innovation, Power, and Global Influence in 2026
